Internet Of Medical Things Market Is Projected to Expand At A CAGR Of 21% Between 2024 And 2032

12 Feb 2024

The healthcare industry has been significantly impacted by the Internet of medical things (IoMT), which utilizes interconnected devices to optimize patient care, expedite operations, and increase overall productivity. Ahead of schedule from 2024 to 2032, the Internet of medical things is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 21%. This expansion will be fueled by developments in wearable technology, data interoperability, and the expansion of telehealth. Although data security continues to be a substantial apprehension, the IoMT market is positioned for substantial expansion, propelled by the emergence of services, cloud deployment, and the Asia-Pacific region. In the future years, the IoMT is anticipated to have a greater influence on healthcare delivery and patient outcomes as industry titans pave the way for innovation.

The emergence of wearable devices featuring health-monitoring sensors has become a fundamental aspect of the Internet of Things (IoMT). Prominent technology companies such as Apple, Fitbit, and Samsung showcased the capabilities of wearables in 2023, including the monitoring of vital signs, identification of irregularities, and advocacy for proactive healthcare. The pervasive integration of sleep tracking, electrocardiogram (ECG), and continuous glucose monitoring (CGM) functionalities into wearables facilitated a paradigm shift in the direction of preventive healthcare.

The advancement of IoMT has been significantly aided by the seamless exchange and assimilation of healthcare data across a multitude of systems and devices. In 2023, interoperability-promoting initiatives acquired momentum, including Fast Healthcare Interoperability Resources (FHIR). An interconnected ecosystem was established through the collaboration of healthcare providers and technology companies, such as Epic Systems, Cerner, and Allscripts. This ecosystem was designed to improve the accessibility and accuracy of patient information.

Browse for report at :

The increase in worldwide implementation of telehealth solutions and remote patient monitoring systems in 2023 can be attributed to the demand for healthcare services that are both accessible and efficient. Prominent corporations such as Philips, Amwell, and Teladoc were instrumental in the expansion of virtual care options. The implementation of IoMT devices facilitated the ability of healthcare practitioners to oversee the health status of patients from a distance, thereby enabling prompt interventions and alleviating the strain on conventional healthcare infrastructure.

Notwithstanding the encouraging progressions, a significant impediment in the realm of IoMT pertained to apprehensions surrounding data security and privacy. Aware that unauthorized access to patient data and cyberattacks against healthcare networks would occur in 2023, concerns were elevated among healthcare providers and patients alike. The critical significance of securing sensitive medical information was underscored by breaches reported by organizations such as HIMSS and the U.S. Department of Health and Human Services, which demonstrated the need for robust cybersecurity measures.

The hardware, software, and services sectors comprise the IoMT market. The software segment generated the most revenue in 2023, primarily due to the increased demand for interoperability platforms, connectivity solutions, and data analytics. On the contrary, the services sector is anticipated to experience the most substantial Compound Annual Growth Rate (CAGR) from 2024 to 2032. This underscores the growing demand for implementation, support, and maintenance services within the dynamic IoMT environment.

The IoMT deployment outlook comprises both on-premise and cloud-based solutions. Revenue-wise, the on-premise deployment model dominated in 2023, as healthcare organizations placed a premium on data infrastructure control. However, it is expected that the cloud deployment model will continue to grow at the maximum CAGR over the projected timeframe. This can be attributed to the industry's transition towards cloud solutions that are adaptable, scalable, and economical.

On a global scale, the IoMT market exhibited a wide range of trends. North America led in revenue and compound annual growth rate in 2023, owing to substantial investments in healthcare infrastructure and technology. During the forecast period, the Asia-Pacific region is anticipated to witness the most substantial compound annual growth rate (CAGR), suggesting substantial prospects for expansion and heightened implementation of IoMT solutions in developing economies.

Apple Inc., Fitbit, Samsung, Epic Systems, Cerner, Allscripts, Teladoc, Amwell, Philips, Boston Scientific Corporation, Biotronik SE & Co. KG, Cisco Systems, Inc., General Electric Company, Honeywell International Inc., IBM Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lenovo Group Ltd., Medtronic plc, Neurometrix, Inc., Microsoft Corporation, SAP SE, and Siemens AG are the leading participants in the IoMT market. To remain competitive, these businesses employ a variety of strategies, including partnerships, acquisitions, and product innovations. Their revenues demonstrated market leadership in 2023, and they anticipate continued expansion throughout the projected timeframe.

View Other Reports